PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search
BNF Chapter
BNF Paragraph
Please select a BNF Chapter.
Search Results : Attention Deficit Hyperactivity Disorder (ADHD) - Adults (Guanfacine - Attention Deficit Hyperactivity Disorder (ADHD) - Children 6-17yrs)
Records returned : 6 (on 01 Sep 2024 at 10:47:45). Return to search results for ' Attention Deficit Hyperactivity Disorder (ADHD) - Adults '.
Drug
Indication
Status
Trust Alignment
Links
Restrictions/Comments
04.04.00
Amber
Formulations :
- Modified release tablets
ASPH
RSFT
SASH
SABP
Primary Care
04.04.00
Amber
Formulations :
- Modified release tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
Prescribe by brand. Xaggitin XL, Xenidate XL and Delomsart are the locally agreed brands.
Amber
Formulations :
- Immediate release tablets
ASPH
RSFT
SASH
SABP
Primary Care
Important
Prescribe immediate release tablets generically
04.04.00
Amber
Formulations :
- Capsules
ASPH
RSFT
SASH
SABP
Primary Care
04.04.00
Amber
Formulations :
- Tablets
ASPH
RSFT
SASH
SABP
Primary Care
04.04.00
Amber
Formulations :
- Capsules
ASPH
RSFT
SASH
SABP
Primary Care
For information about the icons and status values within this site, please refer to the keys below.
Icon/Links Key
NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply
SA
Safety Alert
U
Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
CDF
ICB
Treatment commissioned by the ICB
BlueTeq form to be completed
NICE
Traffic Light Status Key
Red
Amber
Green
Black
Amber Star
Green (see narrative)
Non Formulary
See Below
N/A
Blue
Green - Black
See narrative
Do not initiate in new patients